Zoledronic acid prevents bone mineral density loss in premenopausal women receiving adjuvant treatment for hormone receptor-positive breast cancer: Preliminary results of a randomized, multicenter trial of zoledronic acid in patients receiving anastrozole or tamoxifen in combination with goserelin
2014 ◽
Vol 25
(4)
◽
pp. 1369-1378
◽
Keyword(s):
2012 ◽
Vol 48
◽
pp. S150-S151
◽
2017 ◽
Vol 18
(13)
◽
pp. 1357-1362
◽
2014 ◽
Vol 26
(1)
◽
pp. 353-360
◽
2008 ◽
Vol 9
(9)
◽
pp. 840-849
◽
Keyword(s):